Ondansetron Hikma

Ondansetron, the active ingredient in Ondansetron Hikma, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetron Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ondansetron Hikma works ​         ​     ​  ​                           …  …  …  … …  … … … …  …  …  ...

Common     ...